$163.99
0.36% yesterday
NYSE, Jun 23, 10:10 pm CET
ISIN
US14149Y1082
Symbol
CAH

Cardinal Health Stock price

$163.99
+11.24 7.36% 1M
+45.64 38.56% 6M
+45.72 38.66% YTD
+59.09 56.33% 1Y
+110.51 206.64% 5Y
+74.76 83.78% 10Y
+120.33 275.63% 20Y
NYSE, Closing price Mon, Jun 23 2025
+0.59 0.36%
ISIN
US14149Y1082
Symbol
CAH
Sector

Key metrics

Market capitalization $39.00b
Enterprise Value $43.35b
P/E (TTM) P/E ratio 25.29
EV/FCF (TTM) EV/FCF 17.77
EV/Sales (TTM) EV/Sales 0.20
P/S ratio (TTM) P/S ratio 0.18
P/B ratio (TTM) P/B ratio negative
Dividend yield 1.24%
Last dividend (FY25) $2.02
Revenue growth (TTM) Revenue growth 0.77%
Revenue (TTM) Revenue $222.13b
EBIT (operating result TTM) EBIT $2.40b
Free Cash Flow (TTM) Free Cash Flow $2.44b
Cash position $3.33b
EPS (TTM) EPS $6.46
P/E forward 23.16
P/S forward 0.17
EV/Sales forward 0.19
Short interest 3.25%
Show more

Is Cardinal Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,880 stocks worldwide.

Cardinal Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Cardinal Health forecast:

14x Buy
74%
4x Hold
21%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Cardinal Health forecast:

Buy
74%
Hold
21%
Sell
5%

Financial data from Cardinal Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
222,127 222,127
1% 1%
100%
- Direct Costs 214,308 214,308
1% 1%
96%
7,819 7,819
6% 6%
4%
- Selling and Administrative Expenses 5,136 5,136
3% 3%
2%
- Research and Development Expense - -
-
-
2,683 2,683
13% 13%
1%
- Depreciation and Amortization 287 287
10% 10%
0%
EBIT (Operating Income) EBIT 2,396 2,396
14% 14%
1%
Net Profit 1,558 1,558
158% 158%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cardinal Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardinal Health Stock News

Positive
Reuters
12 days ago
Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
Neutral
PRNewsWire
12 days ago
Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283 Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth3,4 Raising lon...
Neutral
PRNewsWire
20 days ago
Kendall DL™ Multi System simplifies patient monitoring, drives efficiencies for providers  DUBLIN, Ohio , June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the continuous monitoring of cardiac activity, blood oxygen level and temperature with one point of connecti...
More Cardinal Health News

Company Profile

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Head office United States
CEO Jason Hollar
Employees 48,411
Founded 1979
Website www.cardinalhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today